BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $14,040,590 | +195.6% | 308,178 | +163.2% | 1.41% | +176.0% |
| Q1 2023 | $4,749,576 | +21.9% | 117,100 | +141.9% | 0.51% | +141.5% |
| Q2 2021 | $3,896,000 | -35.1% | 48,400 | -32.0% | 0.21% | -20.9% |
| Q1 2021 | $6,005,000 | -47.5% | 71,200 | -50.1% | 0.27% | -67.0% |
| Q4 2020 | $11,442,000 | -19.8% | 142,600 | -19.6% | 0.81% | -20.8% |
| Q3 2020 | $14,258,000 | -28.1% | 177,300 | -25.2% | 1.03% | -39.4% |
| Q4 2019 | $19,823,000 | +65.6% | 237,060 | +73.2% | 1.69% | +70.9% |
| Q3 2019 | $11,971,000 | +22.7% | 136,860 | +14.9% | 0.99% | +3.4% |
| Q2 2019 | $9,758,000 | +1328.7% | 119,150 | +673.7% | 0.96% | +2026.7% |
| Q4 2016 | $683,000 | -85.5% | 15,400 | -84.4% | 0.04% | -81.7% |
| Q3 2016 | $4,712,000 | +767.8% | 99,000 | +725.0% | 0.25% | +748.3% |
| Q2 2016 | $543,000 | – | 12,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |